Compare ICCM & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ICCM | MGLD |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.4M | 44.8M |
| IPO Year | 2013 | 2021 |
| Metric | ICCM | MGLD |
|---|---|---|
| Price | $0.62 | $1.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 251.7K | 18.8K |
| Earning Date | 03-17-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $34,876,734.00 |
| Revenue This Year | $53.39 | N/A |
| Revenue Next Year | $487.34 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.54 | $0.64 |
| 52 Week High | $1.40 | $1.38 |
| Indicator | ICCM | MGLD |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 62.03 |
| Support Level | $0.58 | $0.86 |
| Resistance Level | $0.62 | $1.37 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 26.34 | 100.00 |
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include U.S. Fund Management through USCF Investments, Food Products via Gourmet Foods and Printstock Products in New Zealand, Beauty Products under the Original Sprout brand, and formerly Security Systems through Brigadier, sold in 2025. The majority of revenue comes from fund management. The company operates in the USA, New Zealand, the United Kingdom, and Canada, with the majority of revenue generated from the USA. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.